Tery Baskin, PharmD, Founder & CEO of RxResults
OUR STORY
The evolution of Evidence-Based Rx Management
The RxResults concept is more a story than strategy, born from one pharmacist's mission to empower his customers with evidence-based pharmacy options.
TERY LISTENED
As a pharmacist, Dr. Baskin listened to his customers, he believed that the customer had a right to know what their options were.
Rx REDEFINED
The approach that Dr. Baskin took with his customers as a pharmacist laid the foundation for the RxResults evidence-based philosophy.
Which of these trends is most concerning to you?
An unbiased, third-party partner is the only way to ensure the dollars you spend on your pharmacy plan are spent with a well thought out plan – implemented by a clinical team with access to the most up-to-date, peer-reviewed, clinically relevant research.
Do you have a plan in place to deal with these trends?
100%
PRICE INCREASES
In 222 generic drug groups prices increased by 100% or more, according to Forbes.
21%
PER YEAR
the average annual cost increase of Specialty Drugs, based on a three year trend
50%
OF DRUGS
that were approved by the FDA in 2015 were considered Specialty Drugs
REQUEST FOR YOUR EXPERIENCE, EXPERTISE & INSIGHTS.
Participate in the RxResults Specialty Drug Spend
Impact Study.
In an effort to complete the industry's most comprehensive and relavent survey on the financial impact of specialty drugs, RxResults is asking Employers, Benefits Consultants and Health Plans to participate in our online survey.
This survey is completely anonymous, consists of approximately 15 multiple choice questions and typically takes less than 10 minutes to complete.
Looking for a way to level the playing field?
